| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 24.281 | 51.182 | 60.989 | 58.380 | 45.726 | 54.213 | 65.215 | 77.435 | 74.614 |
| Total Income - EUR | - | 24.281 | 51.182 | 60.990 | 58.802 | 45.726 | 54.213 | 65.278 | 77.435 | 79.639 |
| Total Expenses - EUR | - | 7.509 | 18.742 | 21.027 | 21.182 | 25.098 | 20.823 | 26.645 | 27.411 | 34.387 |
| Gross Profit/Loss - EUR | - | 16.772 | 32.440 | 39.963 | 37.620 | 20.628 | 33.389 | 38.633 | 50.024 | 45.252 |
| Net Profit/Loss - EUR | - | 16.044 | 31.494 | 39.409 | 37.126 | 20.274 | 32.951 | 38.165 | 49.405 | 43.150 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Gynodermesthet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 10.499 | 7.274 | 4.186 | 20.339 | 17.803 | 13.092 | 9.473 | 28.641 | 50.742 |
| Current Assets | - | 5.378 | 32.284 | 36.827 | 18.227 | 15.541 | 32.238 | 30.930 | 22.640 | 32.125 |
| Inventories | - | 245 | 138 | 0 | 0 | 0 | 0 | 0 | 0 | 503 |
| Receivables | - | 0 | 1.798 | 1.216 | 83 | 259 | 27.870 | 28.653 | 979 | 31.536 |
| Cash | - | 5.133 | 30.348 | 35.611 | 18.144 | 15.281 | 4.368 | 2.276 | 21.661 | 87 |
| Shareholders Funds | - | 16.088 | 37.851 | 39.460 | 37.176 | 32.372 | 32.999 | 38.416 | 49.765 | 43.600 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.780 | 1.748 | 1.552 | 1.462 | 1.167 | 12.331 | 1.986 | 1.516 | 39.288 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Gynodermesthet Srl